/GRDN
GRDN Stock - Guardian Pharmacy Services, Inc.
Healthcare|Medical - DistributionNYSE
$31.54+1.25%
+$0.39 (+1.25%) • Dec 19
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.97
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).49
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.82
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+-0.7%upside
Target: $31.32
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for GRDN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$31.22 – $31.86
TARGET (TP)$31.33
STOP LOSS$29.02
RISK/REWARD1:-0.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.96
52W High$37.43
52W Low$17.78
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $1.23B | $1.05B | $908.91M | $792.07M | $735.96M |
| Gross Profit | $244.37M | $208.31M | $185.87M | $161.26M | $147.00M |
| Gross Margin | 19.9% | 19.9% | 20.4% | 20.4% | 20.0% |
| Operating Income | $-62,920,000 | $40.95M | $51.99M | $30.15M | $32.06M |
| Net Income | $-87,287,000 | $23.90M | $35.42M | $16.31M | $19.94M |
| Net Margin | -7.1% | 2.3% | 3.9% | 2.1% | 2.7% |
| EPS | $-1.77 | $0.39 | $0.58 | $0.27 | $0.33 |
Company Overview
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company's Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs. The company was founded in 2003 and is based in Atlanta, Georgia.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
3 Bullish0 Neutral/Bearish
Price Targets
$24
Average Target
↓ 22.8% Downside
Now
$21
Low
$24
Average
$30
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 10th 2025 | Oppenheimer | Initiation | Outperform | $30 |
| October 21st 2024 | Raymond James | Initiation | Outperform | $21 |
| October 21st 2024 | Truist | Initiation | Buy | $22 |
Earnings History & Surprises
GRDNBeat Rate
60%
Last 5 quarters
Avg Surprise
-226.8%
EPS vs Estimate
Beats / Misses
3/2
Last 12 quarters
Latest EPS
$0.25
Q4 2025
EPS Surprise History
Q4 23
No data
Q3 24
No data
Q3 24
No data
Q4 24
-1152.6%
$-2.00vs$0.19
Q1 25
+14.3%
$0.24vs$0.21
Q2 25
-4.5%
$0.21vs$0.22
Q3 25
+4.5%
$0.23vs$0.22
Q4 25
+4.2%
$0.25vs$0.24
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 25, 2026 | $0.27 | — | — | — |
Q4 2025 | Nov 10, 2025 | $0.24 | $0.25 | +4.2% | ✓ BEAT |
Q3 2025 | Aug 11, 2025 | $0.22 | $0.23 | +4.5% | ✓ BEAT |
Q2 2025 | May 12, 2025 | $0.22 | $0.21 | -4.5% | ✗ MISS |
Q1 2025 | Mar 26, 2025 | $0.21 | $0.24 | +14.3% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $0.19 | $-2.00 | -1152.6% | ✗ MISS |
Q3 2024 | Sep 26, 2024 | — | $0.17 | — | — |
Q3 2024 | Aug 22, 2024 | — | $0.24 | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.10 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.19 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.35 | — | — |
Q1 2023 | Mar 31, 2023 | — | $0.03 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.10 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.30 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.07 | — | — |
Q3 2021 | Sep 30, 2021 | — | $0.20 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.00 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.08 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.05 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.02 | — | — |
Latest News
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $34
📈 PositiveBenzinga•Nov 14, 2025, 05:55 PM
Guardian Pharmacy Service shares are trading higher after the company reported Q3 earnings and revenue above estimates and raised its FY2025 sales guidance.
📈 PositiveBenzinga•Nov 11, 2025, 02:38 PM
Guardian Pharmacy Service Raises FY2025 Sales Guidance from $1.390B-$1.410B to $1.430B-$1.450B vs $1.401B Est
📈 PositiveBenzinga•Nov 10, 2025, 09:09 PM
Guardian Pharmacy Service Q3 Adj. EPS $0.25 Beats $0.17 Estimate, Sales $377.427M Beat $354.148M Estimate
📈 PositiveBenzinga•Nov 10, 2025, 09:08 PM
Guardian Pharmacy Services May Offer And Sell Up To 1.02M Shares Of Class A Common Stock; Selling Stockholders May Offer And Sell Up To 4.98M Shares Of Class A Common Stock
📉 NegativeBenzinga•Oct 14, 2025, 08:23 PM
Oppenheimer Initiates Coverage On Guardian Pharmacy Service with Outperform Rating, Announces Price Target of $30
📈 PositiveBenzinga•Oct 10, 2025, 05:49 PM
Truist Securities Maintains Buy on Guardian Pharmacy Service, Raises Price Target to $30
📈 PositiveBenzinga•Sep 26, 2025, 03:19 PM
Frequently Asked Questions about GRDN
What is GRDN's current stock price?
Guardian Pharmacy Services, Inc. (GRDN) is currently trading at $31.54 per share. The stock has moved +1.25% today.
What is the analyst price target for GRDN?
The average analyst price target for GRDN is $31.33, based on 1 analyst.
What sector is Guardian Pharmacy Services, Inc. in?
Guardian Pharmacy Services, Inc. operates in the Healthcare sector, specifically within the Medical - Distribution industry. The company is traded on the NYSE exchange.
What is GRDN's market cap?
Guardian Pharmacy Services, Inc. has a market capitalization of $2.00 billion, making it a small-cap company.
Does GRDN pay dividends?
No, Guardian Pharmacy Services, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorEWTX
Edgewise Therapeutics, Inc.
$25.55
Mkt Cap: $2.7B
JANX
Janux Therapeutics, Inc.
$13.79
Mkt Cap: $0.8B
MD
Pediatrix Medical Group, Inc.
$21.91
Mkt Cap: $1.9B
MESO
Mesoblast Limited
$19.48
Mkt Cap: $2.5B
NHC
National HealthCare Corporation
$141.64
Mkt Cap: $2.2B
NUVB
Nuvation Bio Inc.
$9.44
Mkt Cap: $3.2B
PRCT
PROCEPT BioRobotics Corporation
$32.06
Mkt Cap: $1.8B
QDEL
QuidelOrtho Corporation
$28.95
Mkt Cap: $2.0B
TWST
Twist Bioscience Corporation
$32.51
Mkt Cap: $1.9B
TXG
10x Genomics, Inc.
$16.05
Mkt Cap: $2.0B
Explore stocks similar to GRDN for comparison